Gabriel Barros Aulicino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gabriel Barros Aulicino has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Fabiana Goulart Marcondes Braga
Universidade de São Paulo
4 shared publications Danielle Louvet Guazzelli
Núcleo de Transplante Cardíaco do Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
3 shared publications- Manuela Cristina Ribeiro Dias Barroso
Universidade de São Paulo, Brasil
3 shared publications - Mônica Samuel Avila
Instituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade Medicina, Universidade de Sao Paulo, Brazil
3 shared publications - Samuel Padovani Steffen
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Unidade de Transplante, Departamento de Cirurgia Cardiovascular
3 shared publications Fabio Antonio Gaiotto
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Brasil
2 shared publications
Latest Publications
- Open Access
- 17 September 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (28) , 105370
Patent Foramen Ovale Shunting Induced by Tricuspid Regurgitation
- 17 September 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (28) , 105370
Open AccessPatent Foramen Ovale Shunting Induced by Tricuspid Regurgitation
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (10)
Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction
Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (10)
Open AccessCardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction
Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (10) , e20250311
Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto
Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (10) , e20250311
Open AccessReativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto
Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 40 (6)
History and Application of Mechanical Assist Devices as a Bridge to Heart Transplant: A Review and Perspectives in Brazil
Mechanical circulatory support (MCS) devices have evolved significantly over the past decades and play a vital role in managing end-stage heart failure, especially as a bridge to heart transplantation. From the pioneering heart-lung machines to third-generation ventricular assist devices (VADs), MCS technology has advanced to provide more durable, efficient, and safer options for both shortand long-term support. This review outlines the historical development of mechanical assist devices, the types of available supports - ranging from intra-aortic balloon pumps and extracorporeal membrane oxygenation to implantable devices like HeartMate 3 - and their clinical indications and complications. Special attention is given to right ventricular dysfunction, thromboembolic and hemorrhagic complications, and infections, which remain major challenges in the management of patients with MCS devices.In Brazil, despite the growing evidence supporting MCS in critically ill patients, access remains limited due to financial and systemic constraints. The review explores the current landscape of device availability in the country, national guidelines, cost-effectiveness data, and the impact of recent changes in transplant allocation criteria that prioritize patients receiving mechanical support. Notably, the approval of long-term VADs for destination therapy in the public health system in 2024 marks a significant milestone.This review offers a comprehensive perspective on MCS utilization, highlighting both global advances and Brazil-specific challenges. By identifying gaps in access and proposing future directions, it advocates for expanded use of these life-saving technologies to improve survival and quality of life in advanced heart failure patients.
- 1 January 2025
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 40 (6)
Open AccessHistory and Application of Mechanical Assist Devices as a Bridge to Heart Transplant: A Review and Perspectives in Brazil
Mechanical circulatory support (MCS) devices have evolved significantly over the past decades and play a vital role in managing end-stage heart failure, especially as a bridge to heart transplantation. From the pioneering heart-lung machines to third-generation ventricular assist devices (VADs), MCS technology has advanced to provide more durable, efficient, and safer options for both shortand long-term support. This review outlines the historical development of mechanical assist devices, the types of available supports - ranging from intra-aortic balloon pumps and extracorporeal membrane oxygenation to implantable devices like HeartMate 3 - and their clinical indications and complications. Special attention is given to right ventricular dysfunction, thromboembolic and hemorrhagic complications, and infections, which remain major challenges in the management of patients with MCS devices.In Brazil, despite the growing evidence supporting MCS in critically ill patients, access remains limited due to financial and systemic constraints. The review explores the current landscape of device availability in the country, national guidelines, cost-effectiveness data, and the impact of recent changes in transplant allocation criteria that prioritize patients receiving mechanical support. Notably, the approval of long-term VADs for destination therapy in the public health system in 2024 marks a significant milestone.This review offers a comprehensive perspective on MCS utilization, highlighting both global advances and Brazil-specific challenges. By identifying gaps in access and proposing future directions, it advocates for expanded use of these life-saving technologies to improve survival and quality of life in advanced heart failure patients.